3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
13
Carcinoma, Hepatocellular
7
Neoplasms
3
Liver Neoplasms
2
Glioblastoma
2
Gastrointestinal Stromal Tumors
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Piebaldism
1
Patient Compliance
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Stable Metastatic Colorectal Cancer
1
Meningioma
1
Melanoma
1
MCRC
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Metastases
1
Leiomyosarcoma
1
Interventions
pembrolizumab
4
Doxorubicin
3
Specimen Handling
2
spartalizumab
1
regorafenib
1
peposertib
1
liposomal doxorubicin
1
cabozantinib
1
X-Rays
1
Standard of Care
1
Quality of Life
1
Propranolol
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Histiocytoma, Malignant Fibrous
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled